切换至 "中华医学电子期刊资源库"

中华普外科手术学杂志(电子版) ›› 2024, Vol. 18 ›› Issue (02) : 200 -203. doi: 10.3877/cma.j.issn.1674-3946.2024.02.022

论著

Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术中的临床疗效研究
祝启路1, 邹佳悦1, 肖均喜1, 侍阳1,()   
  1. 1. 215000 江苏苏州,苏州大学附属第一医院普外科
  • 收稿日期:2023-06-20 出版日期:2024-04-26
  • 通信作者: 侍阳

Clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy after neoadjuvant chemotherapy

Qilu Zhu1, Jiayue Zou1, Junxi Xiao1, Yang Shi1,()   

  1. 1. Department of General Surgery, the First Affiliated Hospital of Soochow University, Shuzhou Jiangsu Province 215000,China
  • Received:2023-06-20 Published:2024-04-26
  • Corresponding author: Yang Shi
  • Supported by:
    Suzhou Science and Technology Development Plan(SLJ2021001)
引用本文:

祝启路, 邹佳悦, 肖均喜, 侍阳. Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术中的临床疗效研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(02): 200-203.

Qilu Zhu, Jiayue Zou, Junxi Xiao, Yang Shi. Clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy after neoadjuvant chemotherapy[J/OL]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2024, 18(02): 200-203.

目的

探究Easy First策略在新辅助化疗后腹腔镜胰十二指肠切除术(LPD)中的临床疗效。

方法

回顾性分析2019年1月至2021年12月收治的可切除或交界性可切除胰腺癌患者60例资料,所有患者均在新辅助化疗后行LPD,根据手术方法不同分为观察组(n=29例)和传统组(n=31例),观察组采用Easy First策略,术中优先处理胃、空肠和胆总管等,最后处理胰颈及胰腺钩突等顺序完成手术;传统组行传统LPD。采用SPSS 24.0完成数据分析。并发症等计数资料用[例(%)]表示,组间比较采用χ2检验;围手术期指标等计量资料用()表示,组间比较以独立样本t检验;采用Kaplan-Meier法、Log-Rank检验进行生存分析。P<0.05差异有统计学意义。

结果

观察组术中出血量显著少于传统组,引流管拔除时间短于传统组(P<0.05);两组患者手术时间、输血、淋巴结清扫数目、术后住院时间比较,差异均无统计学意义(P>0.05);观察组并发症总发生率虽低于传统组(6.9% vs. 22.6%),但组间差异无统计学意义(P>0.05);两组患者累积总生存率比较(44.8% vs. 38.7%),差异无统计学意义(Log-Rank χ2=1.437,P=0.231)。

结论

在新辅助化疗后LPD术中应用Easy First策略,可在术中及时控制出血,提高手术安全性,相比传统手术方法,更适用于新辅助化疗后局部组织粘连、炎症水肿明显的患者。

Objective

To explore the clinical efficacy of Easy First strategy in laparoscopic pancreaticoduodenectomy (LPD) after neoadjuvant chemotherapy.

Methods

Data of 60 patients with resectable or borderline resectable pancreatic cancer treated from January 2019 to December 2021 were retrospectively analyzed. All patients received LPD after neoadjuvant chemotherapy and were divided into observation group (n=29 cases) and traditional group (n=31 cases) according to different surgical methods. Easy First strategy was adopted in the observation group. The stomach, jejunum and common bile duct were treated first, and the neck of pancreas and uncinate process of pancreas were treated last. Traditional group row traditional LPD. SPSS 24.0 was used to complete the data analysis. Complications and other statistical data were represented by [cases (%)], and χ2 test was used for comparison between groups. Perioperative indicators and other measurement data were represented by (), and inter-group comparison was conducted by independent sample t test. Kaplan-Meier method and Log-Rank test were used for survival analysis. P<0.05 was statistically significant.

Results

The intraoperative blood loss in the observation group was significantly less than that in the traditional group, and the drainage tube removal time was shorter than that in the traditional group (P<0.05). There were no significant differences in operation time, blood transfusion, number of lymph node dissection and postoperative hospital stay between the two groups (P>0.05). The total incidence of complications in the observation group was lower than that in the traditional group (6.9% vs. 22.6%), but there was no significant difference between the two groups (P>0.05). There was no significant difference in cumulative overall survival between the two groups (44.8% vs. 38.7%) (Log-Rank χ2 =1.437, P=0.231).

Conclusion

The application of Easy First strategy in LPD after neoadjuvant chemotherapy can control bleeding in time and improve surgical safety. Compared with traditional surgical methods, EASY First strategy is more suitable for patients with local tissue adhesion, inflammation and edema obvious after neoadjuvant chemotherapy.

表1 胰腺癌两种不同手术方法两组患者一般临床资料比较
表2 胰腺癌两种不同手术方法两组患者围手术期指标比较
表3 胰腺癌两种不同手术方法两组患者并发症情况比较(例)
图1 胰腺癌两种不同手术方法两组患者术后Kaplan-Meier生存曲线
[1]
Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors[J]. Nat Rev Gastroenterol Hepatol2021,18(7):493-502.
[2]
梁先春.静脉切除对门静脉受累胰腺癌根治术患者近期疗效及远期预后的影响[J/CD].中华普外科手术学杂志(电子版),2019,13(04):354-357.
[3]
刘悦泽,张太平,赵玉沛.日本胰腺学会《胰腺癌临床实践指南(2022年版)》更新解读[J].中国实用外科杂志,2023,43(07):772-776.
[4]
李征,虞先濬,徐晓武.胰腺癌新辅助化疗后行腹腔镜胰十二指肠切除术的难点及对策[J].中国实用外科杂志,2022,42(05):526-528.
[5]
张太平,刘悦泽.中国腹腔镜胰十二指肠切除术20年发展、存在问题及对策[J/CD].中华普外科手术学杂志(电子版),2021,15(03):241-244.
[6]
中华医学会外科学分会胰腺外科学组,中国医疗保健国际交流促进会胰腺病分腹腔镜胰十二指肠切除手术专家共识(附:手术流程与主要步骤)[J].中华外科杂志201755(05):5.
[7]
Gugenheim JCrovetto APetrucciani N. Neoadjuvant therapy for pancreatic cancer[J]. Updates Surg2022,74(1):35-42.
[8]
商阳阳,陶俊宇,杨佳丽,等.交界可切除和局部进展期胰腺癌行新辅助化疗的疗效分析[J].中国普通外科杂志,2023,32(03):336-345.
[9]
Ye MZhang QChen Y,et al. Neoadjuvant chemotherapy for primary resectable pancreatic cancer: a systematic review and meta-analysis[J]. HPB(Oxford)2020,22(6):821-832.
[10]
Truty MJKendrick MLNagorney DM,et al. Factors Predicting Response,Perioperative Outcomes,and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer[J]. Ann Surg2021,273(2):341-349.
[11]
Mikulic DMrzljak A. Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy[J].World J Clin Cases2021,9(20):5398-5407.
[12]
孟庆才,王巍.胰腺癌新辅助化疗策略选择及手术时机[J].肝胆外科杂志,2022,30(01):73-75.
[13]
耿小平.关于开展腹腔镜胰十二指肠切除术的一些思考[J].中国实用外科杂志,2023,43(01):90-92.
[14]
Yamada KKawashima HOhno E,et al. Diagnosis of vascular invasion in pancreatic ductal adenocarcinoma using endoscopic ultrasound elastography[J]. BMC Gastroenterol2020,20(1):81.
[15]
He YGHuang XBLi YM,et al. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study[J]. World J Gastrointest Oncol2022,14(9):1785-1797.
[1] 燕速, 霍博文. 腹腔镜食管胃结合部腺癌根治性切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 13-13.
[2] 母德安, 李凯, 张志远, 张伟. 超微创器械辅助单孔腹腔镜下脾部分切除术[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 14-14.
[3] 李国新, 陈新华. 全腹腔镜下全胃切除术食管空肠吻合的临床研究进展[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 1-4.
[4] 李子禹, 卢信星, 李双喜, 陕飞. 食管胃结合部腺癌腹腔镜手术重建方式的选择[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 5-8.
[5] 李乐平, 张荣华, 商亮. 腹腔镜食管胃结合部腺癌根治淋巴结清扫策略[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 9-12.
[6] 陈方鹏, 杨大伟, 金从稳. 腹腔镜近端胃癌切除术联合改良食管胃吻合术重建His角对术后反流性食管炎的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 15-18.
[7] 许杰, 李亚俊, 韩军伟. 两种入路下腹腔镜根治性全胃切除术治疗超重胃癌的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 19-22.
[8] 李刘庆, 陈小翔, 吕成余. 全腹腔镜与腹腔镜辅助远端胃癌根治术治疗进展期胃癌的近中期随访比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 23-26.
[9] 任佳, 马胜辉, 王馨, 石秀霞, 蔡淑云. 腹腔镜全胃切除、间置空肠代胃术的临床观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 31-34.
[10] 王庆亮, 党兮, 师凯, 刘波. 腹腔镜联合胆道子镜经胆囊管胆总管探查取石术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 313-313.
[11] 杨建辉, 段文斌, 马忠志, 卿宇豪. 腹腔镜下脾部分切除术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 314-314.
[12] 叶劲松, 刘驳强, 柳胜君, 吴浩然. 腹腔镜肝Ⅶ+Ⅷ段背侧段切除[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(02): 315-315.
[13] 郭兵, 王万里, 何凯, 黄汉生. 腹腔镜下肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 143-143.
[14] 李凯, 陈淋, 苏怀东, 向涵, 张伟. 超微创器械在改良单孔腹腔镜巨大肝囊肿开窗引流及胆囊切除中的应用[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 144-144.
[15] 魏丽霞, 张安澜, 周宝勇, 李明. 腹腔镜下Ⅲb型肝门部胆管癌根治术[J/OL]. 中华肝脏外科手术学电子杂志, 2025, 14(01): 145-145.
阅读次数
全文


摘要